VICKS SINEX NASAL SPRAY OTC
Generic Name and Formulations:
Phenylephrine HCl 0.5%; contains benzalkonium chloride, camphor, eucalyptol, menthol.
Procter & Gamble Pharmaceuticals
Indications for VICKS SINEX NASAL SPRAY:
2–3 sprays in each nostril not more than every 4hrs; max 3 days.
Children <2yrs old.
Cardiovascular disease. Hypertension. Thyroid disease. Diabetes. GI or GU obstruction. Pregnancy. Nursing mothers.
Nasal discomfort (eg, burning, stinging, sneezing), rebound congestion.
Endocrinology Advisor Articles
- Two Phases of C-Peptide Decline Identified in Type I Diabetes
- Dulaglutide Effective for Patients With T2D, Moderate to Severe CKD
- Incidence of Diabetes Influenced by Endocrine-Disrupting Chemicals in the Environment
- Guidelines for Management of Hypothalamic-Pituitary, Growth Disorders in Childhood Cancer Survivors
- Romosozumab: Effective in Men With Osteoporosis
- Using Latent Class Trajectory Analysis to Determine Glucose Response Curve Patterns
- First CGM System With Implantable Glucose Sensor Approved
- Adjunctive Metformin for Insulin Resistance in T1D: A Clinical Perspective
- Risk for Below Knee Amputations With Canagliflozin vs Other Antihyperglycemic Agents
- Empagliflozin, Linagliptin Combination Therapy vs Linagliptin Monotherapy for Type 2 Diabetes
- Testosterone Prescribing Trends in the United States Between 2002 and 2016
- The Future of Food and Drug Regulation: Trump Administration Proposes Reorganization of FDA, USDA
- Popliteal Sciatic Nerve Block May Increase Time to First Opioid Request in Diabetic Peripheral Neuropathy
- Favorable Outcomes With Second-Generation Insulin Analogs in Type 2 Diabetes
- Subclinical Hypothyroidism: Controversies in Testing and Treatment